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Abstract  The  results  of  the  bacteriologic  samples  taken  from  7  orbit-exenterated  patients  who
use orbitofacial  prosthesis  are  presented.  The  objective  was  to  describe  which  microorganisms
colonized  the  prosthesis  and  the  cavity  at  the  beginning,  at  3  months,  and  at  6  months.  The
microbiologic  studies  reported  the  presence  of  Staphylococcus  epidermis  and  Staphylococcus
aureus in  the  exenterated  cavities  in  57%  of  the  patients  and  in  the  orbitofacial  prosthesis  in
14.5% during  the  ﬁrst  month;  in  the  third  month  orbitofacial  prosthesis  Staphylococcus  pyro-
genes in  4  patients  and  exenterated  cavities  S.  epidermis  in  85.7%;  in  the  6th  month  S.  pyrogenes
in 28.5%  (2  patients)  in  orbitofacial  prosthesis  and  S.  epidermis  in  100%  in  the  exenterated  cav-
ities. The  patients  who  already  defeated  the  infection  were  able  to  receive  the  treatment
according  to  the  antibiotic  sensitivity  of  the  microorganism  and  the  change  of  the  prosthesis.
Once the  results  of  the  treatment  are  given,  we  suggest  providing  precise  instructions  to  the
patients  in  order  to  prevent  infection.
© 2016  Sociedad  Mexicana  de  Oftalmología,  A.C.  Published  by  Masson  Doyma
México S.A.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).PALABRAS  CLAVE
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Estudio  bacteriologico  en  protesis  orbitofacial  en  pacientes  exenterados
Resumen  Se  presentan  los  resultados  de  tomas  bacteriológica  llevadas  a  cabo  en  7  pacientes
exenterados  de  órbita  portadores  de  prótesis  orbitofacial.  El  objetivo  fue  describir  qué  microor-
ganismos  colonizan  la  prótesis  y  la  cavidad  al  inicio,  a  los  3  y  a  los  6  meses.  Los  informesPlease  cite  this  article  in  press  as:  Ocampo  García  KG,  et  al.  Bacteriologic  study  of  orbitofacial  prosthetics  in  exenterated
patients.  Rev  Mex  Oftalmol.  2016.  http://dx.doi.org/10.1016/j.mexoft.2015.12.008
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microbiológicos  reportaron  al  primer  mes  en  las  cavidades  exenteradas  Staphylococcus  epi-
dermis y  Staphylococcus  aureus  en  el  57.2%,  en  las  prótesis  orbitofaciales  se  encontraron
Staphylococcus  aureus  en  un  14.5%;  al  tercer  mes,  en  las  prótesis  orbitofaciales  Staphylococcus
pyogenes  en  4  pacientes  y  en  cavidades  exenteradas  Staphylococcus  epidermis  en  el  85.7%;
al sexto  mes  Staphylococcus  pyogenes  en  un  28.5%  (2  pacientes)  para  prótesis  orbitofaciales  y
Staphylococcus  epidermis  en  el  100%  de  las  cavidades  exenteradas.  Los  pacientes  con  la  infec-
ción ya  maniﬁesta  fueron  susceptibles  de  tratamiento  de  acuerdo  a  la  sensibilidad  antibiótica
del microorganismo  y  al  cambio  de  la  prótesis,  y  dados  los  resultados  sugerimos  suministrar
indicaciones  precisas  a  los  pacientes  para  prevenir  infecciones.
© 2016  Sociedad  Mexicana  de  Oftalmología,  A.C.  Publicado  por  Masson  Doyma
México S.A.  Este  es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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rbital  exenteration  is  deﬁned  as  the  total  removal  of  the
issues  contained  in  the  orbital  cavity  (the  eye,  fat,  mus-
le,  and  at  times  the  eyelid).  Some  of  the  most  common
auses  of  orbital  exenteration  are  Mucormycosis  and  ocu-
ar  and  palpebral  tumors,  such  as  retinoblastoma,  squamous
ell  carcinoma,  or  benign  tumors.
Squamous  cell  carcinoma  starts  in  the  squamous  cells,
hin  and  plain  cells  in  the  tissue  that  forms  the  surface  of
he  skin  and  the  coating  of  the  empty  organs  in  the  body.  It
s  the  second  most  frequent  of  the  skin  cancers,  frequently
ccurring  in  people  with  light  skin  and  light  eyes  and  pre-
ominantly  found  in  zones  of  the  skin  which  are  exposed  to
ight.  It  can  appear  as  exophytic  lesions  and  vegetative  or
lcerated  warts,  which  are  quickly-growing  with  the  possi-
ility  of  metastasize.  It  generally  affects  people  60  years
nd  older,  predominantly  in  men  with  a  background  of  pro-
onged  exposure  to  ultraviolet  radiation.  Other  risk  factors
re  heredity,  tar  and  coal,  ionizing  radiation,  scars,  burns,
hronic  ulcers,  osteomyelitis,  and  arsenic.
Mucormycosis  or  Zygomycosis  is  a  chronic  fungal  infec-
ion  that  principally  appears  in  people  with  immunological
isorders  (diabetes  mellitus,  especially  if  it  is  in  ketoaci-
osis;  leukemia,  lymphoma,  and  AIDS,  among  others).  It  is
aused  by  a  fungus  common  in  the  environment,  an  air-
orne  saprophyte  opportunist  of  the  order  Mucorales  and  the
lass  Zygomycota,  that  is  frequently  found  in  the  ground  and
mong  decomposing  vegetables;  most  people  are  exposed
o  this  fungus  every  day,  but  people  with  immune  sys-
em  disorders  are  the  most  susceptible  to  this  infection.
ucormycosis  is  a  rare  pycomycosis  that  includes  species  of
hizopus,  Rhizomucor,  and  Cunningaghamella  that  colonize
he  nostrils,  paranasal  sinuses,  and  intestines,  and  in  any
orm  it  is  labeled  a  vascular  invasion  by  a  wide  hyphae  and
arely  occurring  septate.  The  most  frequent  occurrence  is
hinocerebral  infection  (infection  in  the  paranasal  sinuses
nd  the  brain),  beginning  as  a  paranasal  sinus  infection
hat  progresses  until  the  inﬂammation  of  the  cranial  nerves
an  cause  blood  coagulation  that  blocks  the  vessels  to  the
rain  (thrombosis).  With  symptoms  like  chronic  sinusitis,  itPlease  cite  this  article  in  press  as:  Ocampo  García  KG,  et  al.  Ba
patients.  Rev  Mex  Oftalmol.  2016.  http://dx.doi.org/10.1016/
auses  fever,  ocular  swelling  and  protrusion  of  the  orbit-
al  cavity  (Exophthalmos),  dark  nasal  eschar,  and  ﬂushing
o  the  face  over  the  skin  covering  the  paranasal  sinuses,
S
p
raking  it  painful  and  stiff,  and  one  central  zone  can  become
lackened.1--4
The  exams  for  diagnosing  Rhinocerebral  Mucormycosis
nclude  computerized  axial  tomography,  magnetic  reso-
ance  imaging  (MRI),  and  biopsy  by  deep  zone  aspiration.
he  principal  histologic  discovery  was  ischemic  necrosis  or
emorrhaging.  The  standard  treatment  is  aggressive  surgery
or  removing  all  the  infected  dead  tissue;  surgical  removal
f  the  compromised  tissue  is  critical  and  the  patient  is  prone
o  disﬁgurement  because  it  can  involve  the  removal  of  the
alate  or  nasal  or  ocular  structures;  the  surgical  treatment
ollows  Amphotericin  B administered  in  intravenous  form  or
njected  directly  to  the  spiral  ﬂuid,  repeated  surgical  washes
y  endoscopy,  and  the  use  of  Filgrastim  (Neupogen)  to  avoid
he  colonization  by  Aspergillus  and  Candida  sp.  and  Mucor,
s  a  preventive  measure.5,6
The  exenteration  is  done  on  the  Rhinocerebral  Mucormy-
osis,  which  is  the  most  common  clinical  form  of
ucormycosis,  and  it  was  the  topic  of  our  study  because  our
atients  had  this  kind  of  Mucormycosis.  Post  operational,
he  use  of  orbitofacial  prosthetics  is  employed.7--9
The  success  of  orbitofacial  prosthesis  depends  signiﬁ-
antly  on  the  extension  of  the  defect,  the  material  from
hich  it  was  made,  its  retention  form,  and  some  other
ggregated  factors,  such  as  the  installation  of  the  microor-
anisms  that  cause  some  infection  which  can  signiﬁcantly
lter  the  rehabilitation  of  the  patient  and  his  or  her  quality
f  life.7,8,10,11
The  use  of  facial  prosthesis  started  with  the  Egyptians
ho  used  artiﬁcial  noses  and  ears.  In  1500  BC  the  Chi-
ese  made  nasal  prosthesis  made  from  wood  and  clay.  In
he  16th  century  Ambroise  Pare  described  the  manufac-
ure  of  a  nasal  prosthesis  using  gold,  silver,  and  paper,
ecuring  his  place  as  a  relevant  ﬁgure  in  the  development
f  maxiofacial  prosthesis,  to  be  followed  by  intellectual
uthors  of  contemporary  works  such  as  Pierre  Fauchard,
elaberre,  Claude  Martin,  Gilbert  Kasanjian  and  Converse.
n  the  9th  century  the  orbitalfacial  prosthesis  began  to  be
anufactured  with  materials  such  as  celluloid  and  vulca-
ized  rubber,  which  resulted  in  its  difﬁculty  of  preparation
nd  diminished  convenience.  It  was  at  the  beginning  of  thecteriologic  study  of  orbitofacial  prosthetics  in  exenterated
j.mexoft.2015.12.008
econd  World  War  that  the  use  of  liquid  substances  such  as
re-vulcanized  rubber  latex,  acrylic  resins,  and  polvinilicas
esins  obtained  satisfactory  ascetic  and  functional  results.
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In  the  same  century,  Chalians  noted  the  extraordinary  devel-
opments  in  the  techniques  and  materials  for  rehabilitation
with  the  appearance  of  acrylics,  resilients,  mercaptans,  and
silicones.7,8,12--15
In  1960  Barnhart  conducted  studies  with  ‘‘Silicona,’’  dis-
covering  that  because  of  its  ﬂexibility,  dimensional  stability,
minimum  thermal  conductivity,  resilience,  and  biocompati-
bility  (non-toxic,  non-allergenic,  non-carcinogenic),  it  is  the
ideal  material  in  the  confection  of  the  orbitofacial  prosthe-
sis.  Currently,  the  most  commonly  used  materials  are  MDX
4-4210,  PVC,  resilient  resin  (Palamed),  Silastic  399  (RTV),
and  Poliuretano.16,17
The  material  in  the  prosthesis  that  the  patients  in  the
study  wore  was  made  of  ‘‘Dow  Corning  General  Purpose
Sealant  Clear’’  silicone,  an  elastomer  silicone  in  the  form
of  pasta,  which  is  colorless  but  can  be  pigmented  intrin-
sically  and  extrinsically.  Among  its  characteristics  are  the
penetrating  odor  of  acetic  acid,  a  composition  based  on
metiltriacetoxisilano  and  etiltriacetoxisilano  (among  oth-
ers),  speciﬁc  gravity  of  10.4--25  C,  consistent  low  dielectric,
low  volatility,  viscosity,  undetermined  density  and  solubility,
more  porosity  when  compared  to  medical  grade  silicon,  high
resistance  to  aging  which  does  not  deteriorate  during  use,
and  minimal  ﬂexibility.18
It  is  evident  that  reconstructive  surgery  can  be  more  nat-
ural  and  physiological  than  the  use  of  prosthesis.  However,
the  ﬁeld  of  surgical  action  is  limited  in  many  cases  and  then
the  use  of  a  therapist  is  necessary  to  rehabilitate  the  patient
by  replacing  the  missing  part  with  prosthesis.13,19
In  the  course  of  recent  years  the  techniques  of  pros-
thetics  have  developed  much  thanks  to  notable  progress  in
oncology  in  multiple  ﬁelds.19
Microbiology  is  deﬁned  as  the  science  of  studying  life
forms  of  miniscule  dimensions  called  microorganisms,  which
require  enlargement  apparatus  to  allow  them  to  be  seen.20
Bacteria  is  an  unicellular  organism  able  to  reproduce  by
itself.  There  are  different  kinds  of  bacteria  classiﬁed
by  its  properties  of  growth  (aerobic  and  anaerobic),  its
capacity  to  change  color  (Gram  positive  or  negative),  and
on  its  form  (bacillus  or  rod-shaped,  spirochaete,  coccus,
etc.)20,21
Some  bacteria  produce  infections  in  human  beings.
Infection  is  understood  as  an  illness  produced  by  the
invasion  of  superior  organism  by  a  germ  (bacteria,  virus,
fungus,  etc.).22,23
As  a  consequence  of  the  same  infections,  usually  alter-
ations  of  the  structure  or  function  of  the  compromised  tissue
is  produced,  causing  fever,  general  depression,  and  innu-
merable  symptoms  that  depend  on  the  kind  of  germ  and  the
immunological  reaction  to  the  germ.
In  an  exenterated  cavity  that  has  communication  with
this  anatomy,  you  must  identify  the  kind  of  ﬂora  that  is  usu-
ally  in  the  site,  such  as  the  next  microorganism;  the  level
of  the  pharynx  is  composed  of  hemolytic  Streptococcus. In
the  nasal  sinuses  there  are  cutaneous  germs,  Staphylococ-
cus  epidermidis  and  Corynebacterium; around  20--30%  of
healthy  carrier  hosts  of  Staphylococcus  aureus  at  the  nasal
level.  Staphylococcus  epidermidis, S.  aureus, HaemophilusPlease  cite  this  article  in  press  as:  Ocampo  García  KG,  et  al.  Bac
patients.  Rev  Mex  Oftalmol.  2016.  http://dx.doi.org/10.1016/
spp.,  Streptococcus  pneumoniae, Corynebacterium, Neisse-
riae,  Moraxellae, E.  coli, K.  pneumoniae, P.  aeruginosa,
P.  mirabilis,  Haemophilus  inﬂuenzae, Neumococos, Bac-
teroides,  Veillonela,  Anctinomyces, and  Spirochaete. In  the
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rbital  cavity  it  is  common  to  ﬁnd  Staphylococcus,  Cornye-
acterium,  Hemolytic, Streptococcus, and  Bacillus.
All  this  is  to  recognize  any  potentially  pathogenic
icroorganism  bacteria  of  the  genus  Serratia  and  Pseu-
omonas,  which  could  become  present  in  the  exenterated
avity,  as  well  as  the  prosthesis,  and  cause  possible  bacterial
nfections  of  the  skin  and  soft  tissue  like  cellulite,  necro-
izing  fasciitis,  staphylococcal  pyoderma,  estrptococcica
yoderma,  or  gaseous  gangrene,  among  others.  In  normal
ituations,  this  microorganism  does  not  cause  any  eye  dam-
ge;  however  in  special  circumstances,  such  as  in  the  case
f  eye  lesions,  these  organisms  can  cause  opportunist  infec-
ions.
Among  the  typical  features  of  microorganisms  encoun-
ered  in  bacteriologic  studies  of  patients  with  exenterated
avities  with  an  orbitofacial  prosthesis,  the  most  evident
re:
 Pseudomonas  aeruginosa: opportunistic  pathogens,  Gram
negative  bacilli,  aerobic  that  move  using  a  polar  ﬂagellum
and  possess  an  unusual  citocramo  transporting  electrons  in
its  chain  which  are  detectable  by  an  oxide  test  (with  pos-
itive  oxides).  Sensitive  to  antibiotics  such  as  Meropenem
and  Imipenem.
 Ptaphylococcus  aureus: spherical  bacteria,  Gram  positive
coccus  that  are  facultative  anaerobic  pathogens  that  are
present  in  normal  human  ﬂora.  Sensitive  to  antibiotics
such  as  Levoﬂoxacina  and  Cefepima.
 Streptococcus  milleri  (Anginosus):  Gram  positive  coccus,
facultative  anaerobic.  Sensitive  to  antibiotics  such  as
Rifampicina  and  Cloranfenicol.
 Streptococcus  pyogenes:  Streptococcus  of  group  A  beta
hemolytic,  spherical  bacteria,  coccus  pyogenes  Gram  pos-
itive  facultative  anaerobic  that  ferment  glucose  with
production  of  lactic  acid.  Sensitive  to  antibiotics  such  as
penicillin  and  B-Lactamicos.
The  development  of  the  metabolic  activities  of  the  bacte-
ia  on  human  cells  is  often  the  cause  of  an  infection.24
aterials and methods
his  observational  and  descriptive  study  was  done  with  the
ttached  informed  consent  of  Helsinki.  There  were  seven
ale  patients  with  a  range  of  age  of  40--50.  Of  these,  two
uffered  from  diabetes  mellitus  and  had  exenteration  of  the
eft  orbital  cavity  with  mucormicosis,  and  in  the  remaining
,  three  in  the  right  orbital  cavity  and  2  in  the  left  with
quamous  cell  lineage  tumors.
These  patients  with  tissue  in  optimal  condition  were
iven  orbitofacial  prosthesis  made  of  Dow  Corning  trans-
arent  silicone,  characterized  intrinsically  with  Factor  II
igments  and  according  to  the  characteristics  of  each
atient  (Fig.  2).
The  three  bacteriologic  samples  were  obtained  in  nor-
al  conditions  of  us  and  without  preparation  of  the  tissuesteriologic  study  of  orbitofacial  prosthetics  in  exenterated
j.mexoft.2015.12.008
y  the  patient  (Fig.  1),  with  a half  Stuart  swap  (culturette);
n  a  time  span  ranging  from  the  ﬁrst  month,  to  three  months
nd  to  six  months  for  each  patient;  following  the  method
f  taking  samples  from  the  sites  (exenterated  cavities  and
ARTICLE IN PRESS+ModelMEXOFT-170; No. of Pages 7
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rigure  1  (A)  Patient  with  extended  cavity  exenteration  for
ucormycosis,  left  orbital.
rbitofacial  prosthesis),  assuring  a  representation  of  the
tate  of  the  infection.
These  samples  were  sent  for  cultivation  and  study  in  the
icrobiology  Laboratories,  in  which  Gram  staining  was  done.
he  samples  were  planted  in  Gelosa  Sange  (G+),  Maconckey
G−),  and  Gelosa  Chocolate  (Neisseria),  among  others.  The
ample  was  streaked  for  isolation  and  incubated  at  36 ◦C
or  24  h,  for  later  analysis.  The  bacterial  study  was  done  by
he  semiautomatic  MicroScan  system  method,  which  used  a
eries  of  substratum  of  Dane  Behrig  panels  with  isolation  of
he  obtained  cultures  as  colonies  in  Petri  dishes,  using  dif-
erential  medium  or  the  speciﬁc  selection  (dyeing  according
o  speciﬁc  features)  and  the  identiﬁcation  of  the  bacteria  in
he  majority  of  the  cases  with  a  positive  probability  greater
han  85%.  The  turbidity  of  the  suspension  of  the  colonies
as  adjusted  to  the  McFarland  standard  of  sulfate  of  barium
.5  M.
esults
icroorganisms  present  in  the  exenterated  cavities  once  the
atient  has  an  orbiofacial  prosthesis  are  shown  in  Table  1.
After  the  ﬁrst  month:  Staphylococcus  epidermis  and  S.
ureus  were  observed  in  57%,  Corynebacterium,  Mycobac-
erias  in  14.5%.  S.  aureus  was  found  in  the  orbitofacial
rosthesis  in  14.5%.  In  later  studies,  in  the  third  month
he  two  microorganisms  found  in  the  orbitofacial  pros-
hesis  were  Staphylococcus  pyrogenes  (4  patients)  and  S.
ureus  in  42.8%  (3  patients)  (graph  3),  in  the  exenter-
ted  cavities  S.  epidermis  was  found  in  85.7%,  S.  aureus
n  71.42%,  Staphylococcus  pyogenes  in  57.2%  and  Mycobac-
erium  in  14.5%.  In  the  6th  month  were  S.  pyrogenes  in
8.5%  (2  patients),  P.  aeruginosa  in  28.5%  (Table  2).  ThePlease  cite  this  article  in  press  as:  Ocampo  García  KG,  et  al.  Ba
patients.  Rev  Mex  Oftalmol.  2016.  http://dx.doi.org/10.1016/
qual  combination  of  S.  aureus  with  P.  aeruginosa  in  14.5%  (1
atient),  in  patients  with  orbitofacial  prosthesis  and  exen-
erated  cavities  in  100%.  S.  aureus  and  S.  pyrogenes  in  28.5%
Table  3).
f
p
her  epidermoid,  right  orbit.  (B)  Patient  cavity  exenterado  by
Percentages  presented  in  the  graphic  before  the  ﬁrst
onth  following  the  six  month  described  (graph  1--6).
iscussion
n  the  majority  of  the  patients  in  the  ﬁrst  month  of  use  of  the
rbitofacial  prosthesis,  common  high  airborne  microorgan-
sms  of  natural  habitat  were  identiﬁed,  which  are  associated
ith  hygiene  care  of  the  orbitofacial  prosthesis  in  all
atients,  including  the  exenterated  cavity  in  the  beginning
f  the  rehabilitation  and  later,  in  the  spacing  of  care,  as  a
esult  of  the  patient’s  control  and  the  physical  deterioration
f  the  prosthesis  due  to  a  change  in  temperature  or  light.
The  presence  of  so  many  microorganisms  in  the  prosthesis
nd  the  cavity  varied  according  to  the  immunological  state
f  the  patient,  the  quality  of  hygienic  facial  and  prosthetic
are,  the  care  of  the  orbitofacial  prosthesis,  and  the  rea-
on  for  the  exenteration  (diagnostic  or  ﬁnancial),  because
he  presence  or  absence  of  the  microorganisms  found  to  be
irectly  related  to  systemic  factors  and  the  environment  of
he  exenterated  patient.
The  microorganisms  reported  by  a bacteriological  study
f  the  orbitofacial  prosthesis  and  exenterated  cavity  of  the
atients  who  participated  in  this  study  were  variable,  and
ts  correspondence  depended  on  the  variability  of  the  fac-
ors  associated  with  the  socio-cultural  environment  of  the
atient,  directly  linked  to  his  or  her  hygienic  habits.
The  reported  microorganisms  that  are  related  to  com-
on  high  airborne  ﬂora  high  in  S.  aureus  and  P.  aeruginosa
re  isolated  and  in  combination,  and  represent  71.5%  of
icroorganisms  found  in  the  6th  month  (Chart  6).  S.  aureus
epresents  42.8%  in  the  3rd  month  in  the  case  of  the  orbito-cteriologic  study  of  orbitofacial  prosthetics  in  exenterated
j.mexoft.2015.12.008
acial  prosthesis  (Table  1).
Of  the  microorganisms  found,  it  is  important  to  note  the
resence  of  S.  pyogenes,  which  does  not  belong  to  common
igh  airborne  ﬂora  and  is  a  potential  pathogen.
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Table  1  Results  of  the  bacteriologic  samples.
Patients Month
First  month  Third  month  Sixth  month
Orbitofacial
prosthesis
Exenterated
cavities
Orbitofacial
prosthesis
Exenterated
cavities
Orbitofacial
prosthesis
Exenterated
cavities
Patient  1  Ausencia  S.  epidermis,
S. aureus
Pyogenes  Epidermis  Pyogenes  Epidermis
Patient 2 Ausencia  S.  epidermis,
S. aureus
Aureus  Epidermis  Pseudomonas
aureginosa
Epidermis
Patient 3  Ausencia  Ausencia  Pyogenes  Epidermis  Epidermis,
pyogenes
Patient 4  Ausencia  S.  epidermis,
S. aureus
Aureus  Epidermis  Pseudomonas
aureginosa,
aureus
Epidermis,
aureus
Patient 5  Ausencia  Corynebacterium,
Mycobacte-
rias
Pyogenes  Pseudomonas
aureginosa
Epidermis
Patient 6  Ausencia  S.  epidermis,
S. aureus
Epidermis  Epidermis,
aureus
Patient 7  S.  aureus  Ausencia  Pyogenes,
aureus
Epidermis  Pyogenes  Epidermis,
pyogenes
Table  2  Percentages  of  isolated  microorganisms  in  orbitofacial  prothesis.
Bacteria Month
First  month  Third  month  Sixth  month
No.  patients  %  No.  patients  %  No.  patients  %
Staphylococcus
aureus
1  14.5  3  42.8  1  14.5
Staphylococcus
pyogenes
0 0  4  57.2  2  28.5
Pseudomonas
aeruginosa
0 0  0  0  2  28.5
Staphylococcus
aureus and
Pseudomonas
aeruginosa
0  0  0  0  2  28.5
Total 0  0  7  100  7  100
Table  3  Percentages  of  isolated  microorganisms  in  exenterated  cavities.
Bacteria Month
First  month  Third  month  Sixth  month
No.  patients  %  No.  patients  %  No.  patients  %
S.  epidermis  4  52.2  6  85.5  7  100
Staphylococcus  aureus  4  52.2  0  0  2  28.5
Staphylococcus  pyogenes  0  0  0  0  2  28.5
Corynebacterium  1  14.5  0  0  0  0
Mycobacterias  1  14.5  0  0  0  0Please  cite  this  article  in  press  as:  Ocampo  García  KG,  et  al.  Bac
patients.  Rev  Mex  Oftalmol.  2016.  http://dx.doi.org/10.1016/
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Figure  2  Image  corresponding  to  rehabilitated  patients  with  a  prosthesis  orbitofacial.
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It  is  worth  mentioning  that  description  above  corrob-
rates  the  relationship  of  microorganisms  present  in  the
xenterated  cavities  to  those  found  in  the  orbitofacial  pros-
hesis  in  all  the  cases.
onclusions
he  results  obtained  in  this  study  suggest  that  the  pres-
nce  or  absence  of  microorganisms  and  the  installation  of
he  infectious  processes  depends  upon  adequate  hygienic
abits  of  the  patient,  the  proper  use,  care,  and  replace-
ent  of  each  prosthesis  (the  average  life  of  an  orbitofacial
rosthesis  is  from  6  to  8  months),  and  the  occupation  and
ocio-economic  level  of  each  patient.
Depending  on  the  disease  and  the  diagnosis  of  exentera-
ion,  the  patient  can  be  referred  to  a  prophylactic  therapist,
ith  the  purpose  of  improving  the  quality  of  life  of  patientsPlease  cite  this  article  in  press  as:  Ocampo  García  KG,  et  al.  Bacteriologic  study  of  orbitofacial  prosthetics  in  exenterated
patients.  Rev  Mex  Oftalmol.  2016.  http://dx.doi.org/10.1016/j.mexoft.2015.12.008
ith  orbitofacial  prosthesis.
Attention  to  details  in  all  stages  of  treatment  by  the
axiofacial  Prosthesis  specialist  can  assure  a  successful
rosthetic  rehabilitation  (Figs.  2-8).
Micoba cteria s
Figure  7
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